sprite-preloader
Anzeige
Mehr »
Samstag, 16.12.2017 Börsentäglich über 12.000 News von 575 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 936263 ISIN: GB0003385308 Ticker-Symbol: P8W 
Aktie:
Branche
Finanzdienstleistungen
Aktienmarkt
FTSE-250
1-Jahres-Chart
WORLDWIDE HEALTHCARE TRUST PLC Chart 1 Jahr
1-Woche-Intraday-Chart
WORLDWIDE HEALTHCARE TRUST PLC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
28,081
29,074
15.12.
07.12.2017 | 16:31
(3 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

PR Newswire
London, December 7

WORLDWIDE HEALTHCARE TRUST PLC

7 December 2017

Allotment of Ordinary Shares

WORLDWIDE HEALTHCARE TRUST PLC (the "Company') announces the allotment of 57,000 Ordinary shares of 25p each fully paid from its block listing authority.

These Ordinary shares were issued today at a price of 2441.75 pence per share, which equates to a premium to the estimated ex dividend cum income net asset value at the time of transaction of 0.7%. The ex dividend cum income net asset value per Ordinary share at the close of business on 6 December 2017 was 2425.24 pence per share.

These shares were issued from its block listing authority dated 27 September 2017. Following this issue, the Company has the ability to issue a further 678,977 shares under its block listing authority.

Following this transaction the Company hereby notifies the market that it has in issue 48,758,778 Ordinary shares of 25p each all with voting rights. No shares were held in treasury at the date of announcement.

The figure of 48,758,778 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 008 4913


© 2017 PR Newswire